Patents by Inventor Joakim Nilsson

Joakim Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11584778
    Abstract: A fusion protein is provided, comprising i) a biologically active polypeptide; and ii) a half-life extending polypeptide moiety comprising 2-80 units independently selected the amino acid sequences according to SEQ ID NO: 1: X1-X2-X3-X4-X5-X6-D-X8-X9-X10-X11 (SEQ ID NO: 1) in which, independently: X1 is P or absent; X2 is V or absent; X3 is P or T; X4 is P or T; X5 is T or V; X6 is D, G or T; X8 is A, Q or S; X9 is E, G or K; X10 is A, E P or T; and X11 is A, P or T. The half-life extending polypeptide moiety has a generally unfolded conformation and provides a fusion protein with a large hydrodynamic radius that may avoid renal clearance. As a result, the biological half-life of the fusion protein is increased and the biological effect of the biologically active polypeptide may thus be prolonged.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: February 21, 2023
    Assignee: Swedish Orphan Biovitrum AB (publ)
    Inventors: Joakim Nilsson, Erik Nordling, Stefan Svensson Gelius
  • Publication number: 20210403533
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-1 receptor type-I (IL-1R-I) which comprise the binding motif (BM) EX2X3X4X5X6X7EIX10X11LPNLX16RX18QYX21AFIX25X26LX28D. The present disclosure also relates to the use of such an IL-1R-I binding polypeptide as a therapeutic, prognostic and/or diagnostic agent.
    Type: Application
    Filed: April 3, 2018
    Publication date: December 30, 2021
    Inventors: Joachim Feldwisch, Malin Lindborg, Joakim Nilsson, Erik Nordling, Robert Svensson
  • Publication number: 20210284690
    Abstract: A fusion protein is provided, comprising i) a biologically active polypeptide; and ii) a half-life extending polypeptide moiety comprising 2-80 units independently selected the amino acid sequences according to SEQ ID NO: 1: X1-X2-X3-X4-X5-X6-D-X8-X9-X10-X11 (SEQ ID NO: 1) in which, independently: X1 is P or absent; X2 is V or absent; X3 is P or T; X4 is P or T; X5 is T or V; X6 is D, G or T; X8 is A, Q or S; X9 is E, G or K; X10 is A, E P or T; and X11 is A, P or T. The half-life extending polypeptide moiety has a generally unfolded conformation and provides a fusion protein with a large hydrodynamic radius that may avoid renal clearance. As a result, the biological half-life of the fusion protein is increased and the biological effect of the biologically active polypeptide may thus be prolonged.
    Type: Application
    Filed: April 16, 2018
    Publication date: September 16, 2021
    Inventors: Joakim Nilsson, Erik Nordling, Stefan Svensson Gelius
  • Patent number: 9994626
    Abstract: The invention relates to a polypeptide capable of binding human complement component 5 (C5), said polypeptide comprising the amino acid sequence (SEQ ID NO: 296) [BM]-[L2]-QSX42X43LLX46EAKKLX52X53X54Q wherein [BM] is a C5 binding motif; [L2] is an interconnecting loop; X42 is selected from A and S; X43 is selected from N and E; X46 is selected from A, S and C; X52 is selected from E, N and S; X53 is selected from D, E and S, provided that X53 is not D when X52 is N; and X54 is selected from A and S.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: June 12, 2018
    Assignee: Swedish Orphan Biovitrum AB (publ)
    Inventors: Joakim Nilsson, Erik Nordling, Patrik Strömberg
  • Patent number: 9982022
    Abstract: The present disclosure relates to a class of engineered polypeptides and provides a polypeptide comprising the sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55). The present disclosure also relates to populations of polypeptide variants based on a common scaffold, each polypeptide in the population comprising the amino acid sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55), and methods for selecting a desired polypeptide having an affinity for a predetermined target from said population.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: May 29, 2018
    Assignee: AFFIBODY AB
    Inventors: Erik Nordling, Joakim Nilsson, Patrik Strömberg
  • Patent number: 9596842
    Abstract: An apparatus intended for evaluation, preservation and perfusion of an organ, such as a lung. The apparatus includes a container with a bottom portion, an insert portion and a lid portion. A pulmonary artery tube is intended to be connected to the lung pulmonary artery and a trachea tube is intended to be connected to the trachea of the lungs and bent tube connects the pulmonary artery tube to a circuit for providing a fluid to the pulmonary artery is provided. The circuit includes a pump, an oxygenator, an optional leukocyte-filter, and a holder for connecting the trachea tube to a source of respiration. There is an oxygenator tube set and a leukocyte-filter tube set. A supporting structure for the container comprises a recess sized for enclosing said container and a display panel. Moreover, there are two handles, which may be unfolded into a position for supporting a sterile cloth.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: March 21, 2017
    Assignee: Vivoline Medical AB
    Inventors: Stig Steen, Audrius Paskevicius, Anna Beyer, Morgan Johansson, Benjamin King, Anna Söderlund, Anders Lindsten, Peter Sebelius, Maria Sperlingsson, Joakim Nilsson
  • Publication number: 20160311870
    Abstract: The invention relates to a polypeptide capable of binding human complement component 5 (C5), said polypeptide comprising the amino acid sequence (SEQ ID NO: 296) [BM]-[L2]-QSX42X43LLX46EAKKLX52X53X54Q wherein [BM] is a C5 binding motif; [L2] is an interconnecting loop; X42 is selected from A and S; X43 is selected from N and E; X46 is selected from A, S and C; X52 is selected from E, N and S; X53 is selected from D, E and S, provided that X53 is not D when X52 is N; and X54 is selected from A and S.
    Type: Application
    Filed: August 28, 2014
    Publication date: October 27, 2016
    Inventors: Joakim Nilsson, Erik Nordling, Patrik Strömberg
  • Publication number: 20160200772
    Abstract: The present disclosure relates to a class of engineered polypeptides and provides a polypeptide comprising the sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21 AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55). The present disclosure also relates to populations of polypeptide variants based on a common scaffold, each polypeptide in the population comprising the amino acid sequence EX2X3X4AX6X7EIX10 X11 LPNLX16X17X18QX20 X21 AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55), and methods for selecting a desired polypeptide having an affinity for a predetermined target from said population.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 14, 2016
    Inventors: Erik Nordling, Joakim Nilsson, Patrik Strömberg
  • Patent number: 9307497
    Abstract: Methods and devices to dynamically determine suitable cell-specific RoT limits are provided. The suitable cell-specific RoT limits can advantageously be set both with respect to a short time scale and a long time scale In accordance with some embodiments the long term time scale operation is based on UE measurements representative for the intended coverage area of the cell. In accordance with some embodiments the short term time scale operation is based on UE measurements from active User Equipments only. Furthermore, also receiver capabilities of and cell isolation to neighboring base stations can be considered in the long time scale operation.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: April 5, 2016
    Assignee: TELEFONAKTIEBOLAGET L M ERICSSON
    Inventors: Mats Blomgren, Fredrik Gunnarsson, Joakim Nilsson
  • Publication number: 20150342178
    Abstract: An apparatus intended tor evaluation, preservation and perfusion of an organ, such as a lung. The apparatus includes a container with a bottom portion, an insert portion and a lid portion. A pulmonary artery tube is intended to be connected to the lung pulmonary artery and a trachea tube is intended to be connected to the trachea of the lungs and bent tube connects the pulmonary artery tube to a circuit for providing a fluid to the pulmonary artery is provided. The circuit includes a pump, an oxygenator, an optional leukocyte-filter, and a holder for connecting the trachea tube to a source of respiration. There is an oxygenator tube set and a leukocyte-filter tube set. A supporting structure for the container comprises a recess sized for enclosing said container and a display panel. Moreover, there are two handles, which may be unfolded into a position for supporting a sterile cloth.
    Type: Application
    Filed: July 16, 2015
    Publication date: December 3, 2015
    Applicant: VIVOLINE MEDICAL AB
    Inventors: Stig STEEN, Audrius Paskevicius, Anna Beyer, Morgan Johansson, Benjamin King, Anna Söderlund, Anders Lindsten, Peter Sebelius, Maria Sperlingsson, Joakim Nilsson
  • Patent number: 9084416
    Abstract: An apparatus intended for evaluation, preservation and perfusion of an organ, such as a lung. The apparatus includes a container with a bottom portion, an insert portion and a lid portion. A pulmonary artery tube is intended to be connected to the lung pulmonary artery and a trachea tube is intended to be connected to the trachea of the lungs and bent tube connects the pulmonary artery tube to a circuit for providing a fluid to the pulmonary artery is provided. The circuit includes a pump, an oxygenator, an optional leukocyte-filter, and a holder for connecting the trachea tube to a source of respiration. There is an oxygenator tube set and a leukocyte-filter tube set. A supporting structure for the container comprises a recess sized for enclosing said container and a display panel. Moreover, there are two handles, which may be unfolded into a position for supporting a sterile cloth.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: July 21, 2015
    Assignee: VIVOLINE MEDICAL AB
    Inventors: Stig Steen, Audrius Paskevicius, Anna Beyer, Morgan Johansson, Benjamin King, Anna Soderlund, Anders Lindsten, Peter Sebelius, Maria Sperlingsson, Joakim Nilsson
  • Patent number: 9054676
    Abstract: An active circulator for a microwave system. The microwave system includes at least one front-end arrangement. Each front-end arrangement includes a power amplifier function arranged to deliver an amplified output signal via a circulator function to an antenna in a transmit mode. A low noise amplifier function is arranged to amplify an input signal from the antenna via the circulator function in a receive mode. The circulator function is arranged to direct a signal flow between the transmit and receive modes. Each front-end arrangement includes one active circulator. The active circulator includes the power amplifier function, the low noise amplifier function and the circulator function of directing a signal flow. The functions integrated into one module. Also, a method to manufacture the active circulator.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: June 9, 2015
    Assignee: SAAB AB
    Inventors: Hans-Olof Vickes, Joakim Nilsson
  • Publication number: 20140128056
    Abstract: Methods and devices to dynamically determine suitable cell-specific RoT limits are provided. The suitable cell-specific RoT limits can advantageously be set both with respect to a short time scale and a long time scale In accordance with some embodiments the long term time scale operation is based on UE measurements representative for the intended coverage area of the cell. In accordance with some embodiments the short term time scale operation is based on UE measurements from active User Equipments only. Furthermore, also receiver capabilities of and cell isolation to neighboring base stations can be considered in the long time scale operation.
    Type: Application
    Filed: June 7, 2011
    Publication date: May 8, 2014
    Applicant: Telefonaktiebolaget L M Ericsson (publ)
    Inventors: Mats Blomgren, Fredrik Gunnarsson, Joakim Nilsson
  • Patent number: 8610502
    Abstract: An amplifier stage in a radar system including an input matching stage, a transistor stage and an output matching stage. At least one of the matching stages includes a switch. Each switch is arranged to connect or disconnect a corresponding at least one grounded matching component to or from the matching stage. Each switch in the matching stages of the amplifier stage is a switch that is arranged to connect or disconnect grounded matching components to or from the matching stages.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: December 17, 2013
    Assignee: SAAB AB
    Inventor: Joakim Nilsson
  • Patent number: 8547176
    Abstract: A distributed power amplifier arranged to operate over a bandwidth. An input side with an input terminal is arranged to receive an input signal and connected to an input transmission line. An output side with an output terminal is adapted to deliver an output signal and connected to an output transmission line. A power splitter is connected to the input terminal, thus being arranged to divide the input signal in a first path to the input transmission line and in a second path to an input of an active matching circuit. The active matching circuit has an output connected to the output transmission line. The other end of the output transmission line is connected to the output terminal. A method to design a distributed power amplifier and to modify existing distributed power amplifiers.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: October 1, 2013
    Assignee: SAAB AB
    Inventors: Joakim Nilsson, Hans-Olof Vickes
  • Publication number: 20130169367
    Abstract: An active circulator for a microwave system. The microwave system includes at least one front-end arrangement. Each front-end arrangement includes a power amplifier function arranged to deliver an amplified output signal via a circulator function to an antenna in a transmit mode. A low noise amplifier function is arranged to amplify an input signal from the antenna via the circulator function in a receive mode. The circulator function is arranged to direct a signal flow between the transmit and receive modes. Each front-end arrangement includes one active circulator. The active circulator includes the power amplifier function, the low noise amplifier function and the circulator function of directing a signal flow. The functions integrated into one module. Also, a method to manufacture the active circulator.
    Type: Application
    Filed: June 18, 2010
    Publication date: July 4, 2013
    Applicant: SAAB AB
    Inventors: Hans-Olof Vickes, Joakim Nilsson
  • Publication number: 20120184024
    Abstract: An apparatus intended for evaluation, preservation and perfusion of an organ, such as a lung. The apparatus includes a container with a bottom portion, an insert portion and a lid portion. A pulmonary artery tube is intended to be connected to the lung pulmonary artery and a trachea tube is intended to be connected to the trachea of the lungs and bent tube connects the pulmonary artery tube to a circuit for providing a fluid to the pulmonary artery is provided. The circuit includes a pump, an oxygenator, an optional leukocyte-filter, and a holder for connecting the trachea tube to a source of respiration. There is an oxygenator tube set and a leukocyte-filter tube set. A supporting structure for the container comprises a recess sized for enclosing said container and a display panel. Moreover, there are two handles, which may be unfolded into a position for supporting a sterile cloth.
    Type: Application
    Filed: September 24, 2010
    Publication date: July 19, 2012
    Applicant: VIVOLINE MEDICAL AB
    Inventors: Stig Steen, Audrius Paskevicius, Anna Beyer, Morgan Johansson, Benjamin King, Anna Soderlund, Anders Lindsten, Peter Sebelius, Maria Sperlingsson, Joakim Nilsson
  • Publication number: 20120086511
    Abstract: A distributed power amplifier arranged to operate over a bandwidth. An input side with an input terminal is arranged to receive an input signal and connected to an input transmission line. An output side with an output terminal is adapted to deliver an output signal and connected to an output transmission line. A power splitter is connected to the input terminal, thus being arranged to divide the input signal in a first path to the input transmission line and in a second path to an input of an active matching circuit. The active matching circuit has an output connected to the output transmission line. The other end of the output transmission line is connected to the output terminal. A method to design a distributed power amplifier and to modify existing distributed power amplifiers.
    Type: Application
    Filed: June 11, 2009
    Publication date: April 12, 2012
    Applicant: SAAB AB
    Inventors: Joakim Nilsson, Hans-Olof Vickes
  • Publication number: 20110169571
    Abstract: An amplifier stage in a radar system including an input matching stage, a transistor stage and an output matching stage. At least one of the matching stages includes a switch. Each switch is arranged to connect or disconnect a corresponding at least one grounded matching component to or from the matching stage. Each switch in the matching stages of the amplifier stage is a switch that is arranged to connect or disconnect grounded matching components to or from the matching stages.
    Type: Application
    Filed: September 12, 2008
    Publication date: July 14, 2011
    Applicant: SAAB AB
    Inventor: Joakim Nilsson
  • Patent number: RE49495
    Abstract: The present disclosure relates to a class of engineered polypeptides and provides a polypeptide comprising the sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55). The present disclosure also relates to populations of polypeptide variants based on a common scaffold, each polypeptide in the population comprising the amino acid sequence EX2X3X4AX6X7EIX10 X11LPNLX16X17X18QX20 X21AFIX25X26LX28X29X30 PX32QSX35X36LLX39E AKKLX45X46X47Q (SEQ ID NO: 55), and methods for selecting a desired polypeptide having an affinity for a predetermined target from said population.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: April 18, 2023
    Assignee: AFFIBODY AB
    Inventors: Erik Nordling, Joakim Nilsson, Patrik Strömberg